NEW YORK, March 20 – Celera Genomics said Tuesday it had appointed Lothar Krinke vice president, business development and strategic planning.
In his new position Krinke, who previously worked at management consulting firm A.T. Kearney, will be responsible for overseeing potential mergers and acquisitions as well as expanding the company’s information business.
A company spokesperson was not immediately available to comment on the company’s current business strategy.
Krinke has a PHD in molecular biology from the State University of New York Albany. He also held an American Cancer Society Postdoctoral Fellowship at the California Institute of Technology.